live attenuated varicella virus oka strain

Ukraine

Drugs containing this active substance

VARILRIX™/VARILRIX™ VACCINE FOR PREVENTION OF VARICELLA LIVE ATTENUATED

The vaccine is used for active immunization against varicella. It is prescribed to healthy individuals (starting from 9 months of age), as well as to persons in close contact with infected individuals or high-risk patients, to reduce the risk of virus transmission.

Form: lyophilisate for solution for injection

Active substance	Dosage
live attenuated varicella virus oka strain	not less than 103.3 IU

ATC: J07BK01

Manufacturer: GlaxoSmithKline Biologicals S.A. (Batch release of finished product, release of solvent batches in ampoules and syringes; labeling and packaging of solvent in ampoules, quality control of solvent in ampoules, labeling and packaging of solvent in syringes, quality control of solvent in syringes, vaccine quality control, labeling and packaging of finished product) / Catalent Belgium (Manufacturing of solvent in syringes, quality control of solvent in syringes)